Replies to post #355355 on NorthWest Biotherapeutics Inc (NWBO)

[trocprofit]

Yes, UK Specials Program.

[ATLnsider]

DCVax-L received “Promising Innovative Medicine” (PIM) designation by the U.K.’s new “Early Access to Medicines Scheme” (EAMS). Like the U.S.’s compassionate use program, the EAMS aims to get urgently needed drug therapies to patients more quickly.

Dr. Ashkan Keyoumars, in the UK, is a big proponent of DCVax-L. He wants “DCVax-L available for all of his GBM patients”:

https://www.bioprocessonline.com/doc/nw-bio-s-cancer-vaccine-first-to-receive-pim-designation-in-u-k-s-early-access-scheme-0001